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Percutaneous transluminal coronary rotational atherec-
tomy (PTCRA) is a coronary intervention in adults with
coronary arterial stenosis caused by heavily calcified
atheroma.1 Kawasaki disease (KD) is one of the most com-
mon forms of pediatric systemic vasculitis.2 Despite
receiving intravenous immunoglobulin therapy, coronary
arterial lesions occur in 5e20% of patients with acute-stage
KD.2,3 Coronary lesions of KD may persist and even progress
to stenosis or obstruction.2 One study reported that aneu-
rysms larger than 8 mm (so-called “giant aneurysms”) did
not regress during a 30-year follow-up period.3 The acute
myocardial infarction/death-free survival rate was only
0.76% and 0.69% at 10 years and 20 years after KD onset,
respectively. A previous report has suggested that PTCRA* Corresponding author. Department of Pediatrics, National
Taiwan University Hospital, and College of Medicine, National
Taiwan University, Number 7, Chung-Shan South Road, Taipei 100,
Taiwan.
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chronic stage of KD.2 However, to the best of our knowl-
edge, no similar study has been conducted in Taiwan.
Herein, we report the results of PTCRA for calcified lesions
in an 11-year-old Taiwanese boy with KD.2. Case Report
An 11-year-old boy (31 kg) experienced two separate epi-
sodes of KD at the ages of 8 months and 11 months. Cardiac
sonography at the age of 11 months revealed giant aneu-
rysms of the left main coronary artery (LMCA; 7.1 mm) and
the right coronary artery (RCA; 7.3 mm). Cardiac cathe-
terization at the age of 8 years revealed aneurysm of the
LMCA, small aneurysm (3.4 mm) of the left circumflex
coronary artery (LCX) with 40% of stenosis (Figure S1A), and
a recanalized RCA with bridging collaterals (Figure S1B).
The stress cardiac scintigram (Tl201) showed a mild revers-
ible perfusion defect at the mid to basal inferior wall. The
patient was regularly taking the following medication: a
low dose of aspirin (3 mg/kg/d), warfarin (2.5 mg once a
day), and diltiazem (15 mg twice a day).by Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
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several angina attacks and cold sweating at school and late
at night. Although emergency laboratory data were within
the normal range (no ST changes on the electrocardiogram
and no elevation of cardiac enzymes), selective coronary
angiography was planned to define any potential progres-
sion of coronary lesions. Femoral vascular access was
established, and heparin (50 units/kg) was administered.
Additional boluses (25 units/kg) of heparin were adminis-
tered during the procedure to maintain an activated clot-
ting time of more than 200 seconds. Selective RCA
angiography revealed similar findings to those of the ex-
aminations 3 years previously. Left coronary cineangiogram
demonstrated: (1) 75% stenosis at the proximal site of the
LCX (white arrowhead in Figure 1A); (2) a giant aneurysm of
the LMCA with wall calcification (white arrow in Figure 1A);
and (3) flow through small collaterals from the LCX to the
distal portion of the occluded RCA (Figure S2).
The left coronary ostium was engaged with a 6-Fr JL3.5
guide catheter for subsequent percutaneous transluminal
coronary angioplasty (PTCA) and possible rotational athe-
rectomy. A Rinato wire (Asahi Intecc, Aichi, Japan) was used
to cross the stenotic lesion in the LCX. Angioplasty was
initially performed with a 2.5 mm  12 mm Trek balloon
(Abbott Vascular, Santa Clara, CA, USA), a 2.5 mm  15 mm
Trek balloon, and then a 2.5mm 12mmNC Sprinter balloon
(Medtronic, Minneapolis, MN, USA) up to 16 atm. However,
we failed to dilate the obstruction by using a balloon angio-
plasty (Figure 1B), and dissection was noted with an easily
collapsed intima flap and compromised flow (black arrow in
Figure 1C). Subsequently, we performed rotational athe-
rectomywith a burr size of 1.25mm (Figure 1D). The burrwas
advanced into and successfully passed through the lesion at
169,000 rotations perminute for 15 seconds. After rotational
atherectomy, a 2.0 mm 8 mm Voyager NC balloon (Abbott)
and a 2.5mm 12mmNCQuantumMaverick balloon (Boston
Scientific, Marlborough, MA, USA) were used to perform
PTCA. The waist finally disappeared. Thereafter, we
deployed a 2.5 mm  14 mm Biomatrix stent (Biosensors,
Singapore, Singapore; Figure 1E) with the balloon inflated to
a pressure of 6 atm, and then performed a poststenting
dilatation with a 2.5 mm NC Quantum Maverick balloon
(Boston Scientific). Excellent antegrade flow and no residual
narrowing were noted after stent deployment (Figure 1F).
Follow-up intravascular ultrasound images revealed
acceptable opposition of the stent to the wall of the LCX.
After the procedure, the child was transferred to an inten-
sive care unit for monitoring and supportive care. T-wave
inversion was noted in the V5 and V6 leads but recovered
rapidly 1 day later. An elevated creatinine kinase level
(786 mg/dL) was detected immediately after the procedure
but normalized 2 days later. Clopidogrel at 37.5 mg and
warfarin at 2.5 mg were administered once daily as anti-
platelet and anticoagulation therapies. Computed tomog-
raphy performed 1 year after the procedure revealed
improved flow in the distal LCX.3. Discussion
We successfully performed rotational atherectomy fol-
lowed by stent implantation in an 11-year-old boy withthree-vessel coronary disease and calcified coronary ste-
nosis caused by KD. To the best of our knowledge, this is the
first pediatric patient with KD to undergo PTCRA and stent
placement in Taiwan. This treatment approach is an
alternative to coronary artery bypass grafting in children
with KD.
A pathological study4 has shown that coronary arterial
stenosis after KD is caused by marked intimal thickening
and multiple calcifications at the site of aneurysms and
stenosis. Such thickening and calcification reduces the
compliance of the arterial wall and compromises the
success of PTCA in patients with KD.5 In this patient, we
failed to advance the follow-up intravascular ultrasound
catheter to the distal lumen of the LCX stenosis before
PTCRA and used a 2.5 mm noncompliant Sprinter balloon
(Medtronic) to conduct PTCA with a maximal balloon
pressure of 16 atm. We not only failed to dilate the ste-
nosis but also created an intima flap and serious dissec-
tion, which is a major cause of new traumatic coronary
aneurysms after PTCA in patients with KD.2,5 The findings
of the current case are supported by the guidelines of the
Japanese Circulation Society,2 which recommend that the
balloon pressure should be less than 10 atm, and that
balloon dilatation is more effective for treating stenotic
lesions developed within 6 years after KD onset. PTCRA is
preferred when calcification exceeds 50% of the lumen or
when severe stenosis fails to respond to balloon
dilatation.
The timing of the intervention is crucial. A coronary
cineangiogram of this patient 3 years earlier (at the age of 8
years; Figure S2) had already revealed an aneurysm of the
LMCA, a recanalized RCA caused by bridging collaterals, the
stenotic LCX (40%), and small collateral from the LCX to
distal RCA. A concurrent thallium-201 perfusion scan also
showed the perfusion defect at the mid to basal inferior
wall. Some researchers4 have claimed that the catheter
intervention should be considered for angiographically sig-
nificant coronary stenotic (>50%) lesions in patients with
KD who have no symptoms, because half of the ischemic
events occurred in the patients with KD who did not have
any previous ischemic findings. However, complications of
PTCA6 and PTCRA, such as restenosis, total occlusion, and
the development of new aneurysms, have also been re-
ported in patients with KD. Currently, the Japanese Circu-
lation Society2 strongly recommends catheter-based
therapy whenever coronary angiographic studies
(computed tomography, magnetic resonance imaging, or
catheterization) show significant stenosis (75% of luminal
diameter) and stress tests reveal ischemic symptoms or
findings. When the patient was aged 8 years, we increased
the dosage of anticoagulants and administered calcium
channel blockers rather than performing a coronary inter-
vention. More frequent follow-up (e.g., every 1 year or 2
years), computed tomography, or magnetic resonance im-
aging for patients with KD and a known history of coronary
stenosis, similar to our case, may promote the earlier
detection of coronary stenosis progression and even in-
crease the probability of successful PTCA in such
patients.2,6
Coronary artery bypass grafting (CABG) is one of the
main treatment options for the revascularization of calci-
fied coronary arterial stenosis after KD. Long-term CABG
Figure 1 Angiogram of the left main coronary artery at the age of 11 years; a giant aneurysm of the left main coronary artery is
noted (white arrow) (A, CeF: Left anterior oblique 60 þ Caudal 20; B: Right anterior oblique 30 þ Caudal 20). (A) Seventy-five
percent stenosis of the left circumflex coronary artery (white arrowhead); (B) limited effect of balloon angioplasty; (C) intima flap
and dissection (black arrowhead); (D) rotational atherectomy with a burr size of 1.25 mm; (E) stent implantation after rotational
ablation; and (F) cineangiogram showing the restored left circumflex coronary artery flow and no stenosis.
250 Y.-C. Wang et alresults in pediatric patients with KD are favorable, with one
study reporting a 20-year survival rate of 95%.7 However, in
the same study, the cardiac event-free rates declined from
85% (10 years) to 68% (25 years).7 Furthermore, the long-
term rate of graft patency (internal thoracic artery) was
relatively higher in patients with KD who were older than 10
years (93%), compared with the rate in those younger than
10 years (86%). According to the aforementioned findings,
we decided to adopt the staged approach (PTCRA followed
by stent implantation) to defer a possible CABG procedureuntil the patient reached young adulthood. In conclusion,
we demonstrated that PTCRA followed by stent implanta-
tion is feasible in a child with KD who has angina associated
with severe calcified coronary stenosis.Conflicts of interest
The authors have no conflicts of interest relevant to this
article.
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